Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Jounce Therapeutics Inc (JNCE)

12.52 -0.29 (-2.26%)

12-15 16:00

Open:

12.81

Pre. Close:

12.81

High:

13.05

Low:

12.5

Volume:

834,859

Market Cap:

404M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

-

-

Low:

-

-

Close:

-

-

Technical analysis  (as of: 2017-12-15 4:57:15 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 17.10     One year: 18.69

Support:

Support1: 12.43    Support2: 10.34

Resistance:

Resistance1: 14.64    Resistance2: 16.00

Pivot:

14.52

Moving Averages:

MA(5): 13.31     MA(20): 14.65

MA(100): 14.65     MA(250):

MACD:

MACD(12,26): -0.48     Signal(12,26,9): -0.19

%K %D:

%K(14,3): 4.92     %D(3): 6.94

RSI:

RSI(14): 27.98

52-Week:

High: 29.29  Low: 11.05  Change(%): -27.4

Average Vol(K):

3-Month: 15436  10-Days 18090

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
JNCE has closed above bottom band by 2.8%. Bollinger Bands are 49.7% wider than normal. The large width of the bands suggest high volatility as compared to JNCE's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.

Headline News

Wed, 25 Jan 2017 07:51:53 GMT
Jounce Therapeutics Inc.

Tue, 14 Nov 2017 18:00:00 GMT
Jounce Therapeutics' (JNCE) CEO Richard Murray Presents at Stifel Nicolaus ...

Fri, 27 Jan 2017 02:26:15 GMT
Jounce Therapeutics Announces Pricing of Initial Public Offering

Sun, 13 Aug 2017 03:56:15 GMT
Jounce Therapeutics' (JNCE) CEO Richard Murray on Q2 2017 Results - Earnings ...

Fri, 27 Jan 2017 11:14:16 GMT
​Cambridge's Jounce raises hopes as first Mass. biotech of 2017 to go public

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

32.25

Shares Float (M)

13.63

% Held by Insiders

15.42

% Held by Institutions

87.33

Shares Short (K)

3270

Shares Short Prior Month (K)

2960

Stock Financials

EPS

-0.230

EPS Est. Current Year

-0.620

EPS Est. Next Year

-0.190

EPS Est. Next Quarter

-0.340

Forward EPS

-0.140

Book Value (p.s.)

5.430

PEG Ratio

Profit Margin

-2.04

Operating Margin

-3.40

Return on Assets (ttm)

-0.6

Return on Equity (ttm)

-1.4

Qtrly Rev. Growth

6.9

Gross Profit (p.s.)

1.153

Sales Per Share

EBITDA (p.s.)

0.042

Qtrly Earnings Growth

Operating Cash Flow (M)

-78.69

Levered Free Cash Flow (M)

-37.96

atoplab.com

Valuation

P/E

-54.43

P/E Growth Ratio

-0.02

P/BV

2.31

P/S

115693416.00

P/CF

-5.13

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.